Riskpilot← Back to searchSign inGet full accessKervanOfSweden AB
ABActiveOrg 5593014508Lavettvägen 41Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
+90% vs 2024
Equity ratio
98.0%
Financial strength
Net profit 2025
SEK -16K
+91% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +90% |
| Net profit | SEK -16K | +91% |
| Total assets | SEK 398K | -39% |
| Equity | SEK 390K | -9% |
| Employees | 0 | — |
Legal name
KervanOfSweden AB
Org number
5593014508
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 februari 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver personalbemanning inom öppenvård till fysiska och digitala apotek samt därmed förenlig verksamhet.
Address
Lavettvägen 41
Email
umuroruc@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 384 | 1 216 | 1 266 | 444 | 0 |
| Staff expenses | — | — | — | −393 | — |
| EBITDA | 150 | 414 | 767 | −112 | −11 |
| Depreciation & amort. | −0 | −39 | −39 | −78 | −0 |
| EBIT | 150 | 375 | 728 | −190 | −11 |
| Net financials | −1 | −4 | — | −2 | −6 |
| Profit before tax | 111 | 263 | 854 | −172 | −16 |
| Tax | −23 | −55 | −177 | — | −0 |
| Net profit | 88 | 208 | 677 | −172 | −16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 300 | 898 | 1 336 | 649 | 398 |
| Equity | 113 | 321 | 799 | 426 | 390 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 149 | 432 | 518 | 222 | 8 |
| Total debt | 149 | 432 | 518 | 222 | 8 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20212025
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
-4.1%
This company
18.4%
Market median
-122% vs market
20212025
Net profit margin
-1600000.0%
This company
8.1%
Market median
-19753186% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UO Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
LS Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KervanOfSweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lisa Sofi A M Karlson Reutercrona | Chief Executive Officer | 0 companies |
| Umur Oruc | Chief Executive Officer | 0 companies |
| Marina Vjacseszlavovna Nyikiforova | Deputy Board Member | 0 companies |
| Wael Samman | Deputy Board Member | 0 companies |